Stimcell Energetics (STME) Free Cash Flow (2011 - 2026)
Stimcell Energetics' (STME) quarterly Free Cash Flow came in at -$86290.0 in Q1 2026, down 97.39% year-on-year from -$3.3 million in Q1 2025, and down 16.39% quarter-over-quarter from -$74138.0 in Q4 2025.
Stimcell Energetics (STME) Free Cash Flow (2011 - 2026) Analysis & Trends
Stimcell Energetics' Free Cash Flow history runs 14 years deep, the most recent figure standing at -$86290.0 for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 97.39% year-over-year to -$86290.0 in Q1 2026; TTM through Feb 2026 was -$327018.0, a 183.33% decrease from a year earlier, with the FY2025 full-year figure at -$141600.0, up 2.95% from the prior year.
- Free Cash Flow retreated to -$86290.0 in Q1 2026 per STME's latest filing, from -$74138.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at -$16519.0 in Q4 2024 and bottomed at -$108142.0 in Q3 2025.
- The 5-year median for Free Cash Flow is -$58448.0 (2025), against an average of -$59448.2.
- Across the five-year window, Free Cash Flow soared 72.91% in 2023 and tumbled 371.89% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$67566.0 in 2022, then soared by 47.71% to -$35328.0 in 2023, then surged by 53.24% to -$16519.0 in 2024, then slumped by 348.8% to -$74138.0 in 2025, then retreated by 16.39% to -$86290.0 in 2026.
- Per Business Quant, the three latest STME Free Cash Flow figures stand at -$86290.0 (Q1 2026), -$74138.0 (Q4 2025), and -$108142.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -86,290.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -86,290.00 |
| Feb 28, 2026 | -86,290.00 |
| Nov 30, 2025 | -74,138.00 |
| Nov 30, 2025 | -74,138.00 |
| Aug 31, 2025 | -108,142.00 |
| Aug 31, 2025 | -108,142.00 |
| May 31, 2025 | -58,448.00 |
| May 31, 2025 | -58,448.00 |
| Feb 28, 2025 | -43,716.00 |
| Feb 28, 2025 | -43,716.00 |
| Nov 30, 2024 | -16,519.00 |
| Nov 30, 2024 | -16,519.00 |
| Aug 31, 2024 | -22,917.00 |
| Aug 31, 2024 | -22,917.00 |
| May 31, 2024 | -32,268.00 |
| May 31, 2024 | -32,268.00 |
| Feb 29, 2024 | -37,945.00 |
| Feb 29, 2024 | -37,945.00 |
| Nov 30, 2023 | -35,328.00 |
| Nov 30, 2023 | -35,328.00 |